About ProxsysRx
ProxsysRx is a company based in Birmingham (United States) founded in 2013. ProxsysRx has raised $14.57 million across 1 funding round from investors including Fulcrum Equity Partners. The company has 138 employees as of December 31, 2020. ProxsysRx offers products and services including Bedside Prescription Delivery, Retail Pharmacy Outsourcing, 340B Optimization, Specialty Pharmacy Setup, and Readmission Risk Reduction. ProxsysRx operates in a competitive market with competitors including mPharma, OmniSYS, Xevant, Pharmagest and Pharmarack, among others.
- Headquarter Birmingham, United States
- Employees 138 as on 31 Dec, 2020
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$14.57 M (USD)
in 1 rounds
-
Latest Funding Round
$14.57 M (USD), Series A
Nov 18, 2020
- Investors
-
Employee Count
138
as on Dec 31, 2020
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of ProxsysRx
ProxsysRx offers a comprehensive portfolio of products and services, including Bedside Prescription Delivery, Retail Pharmacy Outsourcing, 340B Optimization, Specialty Pharmacy Setup, and Readmission Risk Reduction.
Delivers prescriptions directly to patients' bedsides in hospitals.
Manages outpatient retail pharmacies for hospitals at no cost.
Analyzes prescriptions to maximize 340B program returns and compliance.
Assists in establishing and managing specialty pharmacy operations.
Identifies high-risk patients to reduce hospital readmissions through data analysis.
People of ProxsysRx
Unlock access to complete
Funding Insights of ProxsysRx
ProxsysRx has successfully raised a total of $14.57M through 1 strategic funding round. The most recent funding activity was a Series A round of $14.57 million completed in November 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $14.6M
-
First Round
First Round
(18 Nov 2020)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2020 | Amount | Series A - ProxsysRx | Valuation |
investors |
Investors in ProxsysRx
ProxsysRx has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Fulcrum Equity Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments are managed across the United States.
|
Founded Year | Domain | Location |
Investments & Acquisitions by ProxsysRx
Financial Statements - ProxsysRx
Proxsysrx Comparisons
Competitors of ProxsysRx
ProxsysRx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as mPharma, OmniSYS, Xevant, Pharmagest and Pharmarack, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of pharmacy management services and software for stock management for patients and pharmacies
|
|
| domain | founded_year | HQ Location |
Offers medical billing services for pharmacies and manages business policies and relationships.
|
|
| domain | founded_year | HQ Location |
A SaaS-based platform for pharmacy benefit management is provided.
|
|
| domain | founded_year | HQ Location |
Pharmacy management software is developed and integrated for drugstores worldwide.
|
|
| domain | founded_year | HQ Location |
SaaS-based pharmacy management solutions are offered to retailers and distributors.
|
|
| domain | founded_year | HQ Location |
AI-driven pharmacy benefit management software is provided for pharmacies.
|
Frequently Asked Questions about ProxsysRx
ProxsysRx was founded in 2013 and raised its 1st funding round 7 years after it was founded.
ProxsysRx is headquartered in Birmingham, United States. It is registered at Birmingham, Alabama, United States.
ProxsysRx is a funded company, having raised a total of $14.57M across 1 funding round to date. The company's 1st funding round was a Series A of $14.57M, raised on Nov 18, 2020.
As of Dec 31, 2020, the latest employee count at ProxsysRx is 138.
ProxsysRx was founded in 2013 in Birmingham, United States, within the healthcare sector. Operations focus on hospital pharmacy support through outsourcing and optimization. Services encompass bedside prescription delivery, retail pharmacy management, specialty pharmacy setup, and 340B program enhancement. Additional offerings include readmission reduction efforts, employee health savings programs, prescription payment support, and PBM alignment to address operational efficiency and patient care in hospital settings.
ProxsysRx's top competitors include mPharma, Scripta Insights and KareXpert.
ProxsysRx offers Bedside Prescription Delivery, Retail Pharmacy Outsourcing, 340B Optimization, Specialty Pharmacy Setup, and Readmission Risk Reduction.
ProxsysRx has 1 investor. Key investors include Fulcrum Equity Partners.